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Final baricity of ropivacaine or bupivacaine combined with
fentanyl for intrathecal administration
Berrin GÜNAYDIN1, İrfan GÜNGÖR1, Seval İZDEŞ2

Abstract: We determined the baricity of fentanyl-added bupivacaine or ropivacaine with or without dextrose by
analyzing the specific gravity for a better understanding of the final baricity of the intrathecal drug combinations that
are supposed to be used for surgery.
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Introduction
The spread of intrathecal local anesthetics is
determined principally by the baricity of the
injection solution (1,2). Therefore, the choice
of local anesthetic type and its glucose content,
which determines its baricity, are important factors
for achieving an adequate and satisfactory block
for a specific operation. A comparison of the
intrathecal administration of hyperbaric versus
plain local anesthetic drugs revealed that hyperbaric
bupivacaine 0.5% combined with sufentanil resulted
in a greater cephalad spread of spinal block than
bupivacaine 0.5% used alone (3). Additionally, a
higher maximum block height and more rapid onset
of pinprick analgesia at a certain level, such as T10,
was provided with more hyperbaric local anesthetic
solutions (4-6).
Establishing baricity, which is a measure of the
relative density of the local anesthetic solution to the
cerebrospinal fluid (CSF), requires the determination
of density and specific gravity (SG). Density is
determined from the measured weight and volume
and SG is calculated using the density of water at the

same temperature. The SG of normal human CSF
ranges between 1.0063 and 1.0075 and the mean CSF
density of pregnant women was found to be 1.00033
± 0.00010 g/mL (6-8).
In terms of spinal anesthesia, all opioids except
meperidine are hypobaric (8) and all concentrations
of plain bupivacaine and ropivacaine behave
hypobarically at 37 °C (9). For that reason, the
addition of fentanyl, which is also hypobaric, to a
local anesthetic renders the subsequent mixture
even more hypobaric (9). Moreover, normal saline
and 0.5% plain bupivacaine in saline were found to
be hypobaric (10,11). To the best of our knowledge,
however, the density and/or baricity of each local
anesthetic, opioid, or even saline used for intrathecal
route has only been investigated individually in all
of these laboratory studies. We aimed to determine
the final baricity of fentanyl-added bupivacaine
or ropivacaine with or without dextrose in a single
in vitro laboratory set up by analyzing SG in order
to understand the final baricity of the intrathecal
drug combinations that are supposed to be used for
surgery.
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Materials and methods
Four drug solutions (local anesthetic + fentanyl +
saline) were prepared at room temperature (23 °C),
as presented in Table 1. Then these solution samples
were kept in a warm water bath until reaching 37
°C, the point at which the temperature mimics body
temperature (37 °C).
Four solutions for intrathecal use were prepared,
as presented in Table 1. The solutions and their
contents were as follows: Bh, which included
hyperbaric bupivacaine (Marcaine® Spinal heavy,
0.5%, 4 mL ampule, AstraZeneca); Bp, which included
plain bupivacaine (Marcaine® 0.5%, 20 mL flacon,
AstraZeneca); Rh, which was prepared combining
plain ropivacaine (Naropin® 7.5 mg/mL, 10 mL
injection, AstraZeneca) with 0.5 mL 30% dextrose;
and Rp, which included plain ropivacaine (Naropin®
7.5 mg/mL, 10 mL injection, AstraZeneca).
Bupivacaine 10 mg (2 mL) and ropivacaine 15
mg (2 mL) were selected based on the published
studies about the equipotency ratio of 2/3 between
bupivacaine and ropivacaine for intrathecal use coadministered with fentanyl 20 μg (12-15). Fentanyl
20 μg was added to 10 mg of commercially available
0.5% (2 mL) hyperbaric and plain bupivacaine
solutions and to 15 mg of 0.75% (2 mL) plain
ropivacaine solution in the Bh, Bp, and Rp,
respectively. Since there is no commercially available
hyperbaric ropivacaine, 15 mg (0.75%) of plain
ropivacaine was initially combined with glucose

30% to create hyperbaric ropivacaine before 20
μg of fentanyl was added to Rh. Finally, saline was
added to give a final total volume of 3 mL in each
group. The resulting hyperbaric ropivacaine solution
in Rh had a glucose concentration of 5% (50 mg
mL-1), while the commercially available hyperbaric
bupivacaine ampule contained 8% glucose (80 mg
mL-1) and the final glucose concentration in the Bh
was approximately 5.3%.
Afterwards, the SG of each solution was measured
(Combi-screen®, Biotechnologies AG). Written
informed consent was obtained from a parturient
scheduled for a cesarean section (C/S) under spinal
anesthesia in order to collect 3 mL of CSF; this was
used for in vitro laboratory analysis to determine
the SG for the further calculation of baricity. To
determine baricity, the SG of each solution was
divided by the SG of CSF, which was determined to
be 1.005 by Combi-screen®, Biotechnologies AG.
Results
The results of laboratory analysis of the SG and the
baricities of these solutions are presented in Table
2. Solutions containing the commercially available
hyperbaric bupivacaine and the prepared hyperbaric
ropivacaine were confirmed to be hyperbaric. The
solution containing plain bupivacaine was found
to be isobaric and the plain ropivacaine solution
was less isobaric than the solution including plain
bupivacaine (Table 2).

Table 1. Information on the 4 local anesthetic solutions created for intrathecal use.
Solution

Local anesthetic

Dextrose

Fentanyl

Saline

Bh

2 mL 0.5% Heavy Marcaine including 8% dextrose (10 mg bupivacaine)

-

0.4 mL fentanyl (20 μg)

0.6 mL

Bp

2 mL 0.5% Marcaine (10 mg bupivacaine)

-

0.4 mL fentanyl (20 μg)

0.6 mL

Rh

2 mL 7.5 mg/mL Naropin (15 mg ropivacaine)

0.5 mL 30% dextrose

0.4 mL fentanyl (20 μg)

0.1 mL

Rp

2 mL 7.5 mg/mL Naropin (15 mg ropivacaine)

-

0.4 mL fentanyl (20 μg)

0.6 mL

Table 2. Results of the laboratory analysis of specific gravity and the calculation of baricity.

SG at 23 °C
SG at 37 °C
Baricity (SG of local anesthetic/SG of CSF)
Specific gravity: SG,

Bh

Bp

Rh

Rp

1.024
1.023
1.0179

1.005
1.005
1.0000

1.024
1.024
1.0189

1.007
1.006
1.0009

SG of CSF = 1.005
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Discussion
We have determined the final baricities of the 4
solutions including a local anesthetic (bupivacaine
or ropivacaine) and fentanyl combined with saline
to get a final volume of 3 mL where the 2 additives,
fentanyl and saline, were known to be hypobaric. We
demonstrated that the final baricity of the solution
containing plain bupivacaine + fentanyl + saline
was isobaric (1.0000), whereas plain ropivacaine +
fentanyl + saline was less isobaric (1.0009).
When the intrathecal administrations of
hyperbaric and plain drugs were compared for
C/S, hyperbaric bupivacaine 0.5% combined with
sufentanil resulted in a greater cephalad spread of
spinal block than the plain bupivacaine 0.5%. For this
reason, hyperbaric solutions have been considered
more suitable as opposed to their plain equivalents
for C/S (3). Hyberbaric bupivacaine 0.5% including
8% glucose caused a higher sensory block with a
more rapid onset of pinprick analgesia at T10 than
hyperbaric ropivacaine 0.5% including glucose 5%
in patients undergoing lower abdominal, perineal, or
limb surgery (4). Additionally, a higher median block
height and more rapid onset of pinprick analgesia at
T10 have been shown with intrathecal ropivacaine
0.5% containing greater glucose concentrations (50
mg mL-1 vs. 10 mg mL-1) in the same type of operation
(5).
With regard to spinal anesthesia for cesarean
delivery, though hyperbaric bupivacaine is widely
accepted to provide satisfactorily effective anesthesia
(16), a comparably effective spinal block with a
shorter duration of motor block was provided with
hyperbaric ropivacaine (10,17). Currently, hyperbaric

bupivacaine (Bh) and hyperbaric ropivacaine (Rh)
without fentanyl and saline include 80 mg/mL and
50 mg/mL dextrose, respectively. However, the final
glucose concentrations of Bh and Rh with fentanyl
and saline added were 5% and 5.3%, respectively,
resulting in comparably consistent baricities of
1.0179 and 1.0189.
Based on the laboratory investigation of the
density of intrathecal local anesthetics with or
without dextrose, the density of local anesthetics is
inversely proportional to temperature, whereas it
is directly proportional to the addition of dextrose
(9). In accordance with these results, the SG of the
Bh and Rp solutions at 37 °C was lower than the
measurements taken at 23 °C; the Bp and Rh solutions
did not change with increased temperature in the
present investigation, however. Interestingly, the final
baricity of the Bp solution containing fentanyl and
saline was isobaric although plain bupivacaine alone
is considered to be hypobaric at body temperature.
In conclusion, we determined the baricity of
fentanyl-added bupivacaine or ropivacaine with or
without dextrose by analyzing the SG in order to
gain a better understanding of the final baricity of the
intrathecal drug combinations that are supposed to
be used for surgery. Although direct clinical advice
cannot be drawn from a single in vitro laboratory
investigation, determination of the SG and baricity
might be useful before embarking on clinical studies
including spinal anesthesia.
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